Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Erasca, Inc. (ERAS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

accessnewswire.com
ERAS The company is under investigation due to allegations of patent infringement and trade secret misappropriation, leading to a significant drop in its stock price.

Erasca, Inc. (ERAS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Erasca, Inc. ("Erasca" or "the Company") (NASDAQ:ERAS). Investors who purchased Erasca securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ERAS.

Erasca Investigation Details

On April 28, 2026, Erasca disclosed receipt of a letter from Revolution Medicines alleging that Erasca's ERAS-0015 infringes a Revolution patent and is connected to alleged trade secret misappropriation. Following this news, Erasca's stock price fell $9.25 per share, or 48.3%, to close at $9.90 on April 28, 2026.

What's Next for Erasca Investors?

If you are aware of any facts relating to this investigation or purchased Erasca securities, you can assist this investigation by visiting the firm's site: bgandg.com/ERAS. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to Erasca Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Erasca Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE: Bronstein, Gewirtz & Grossman, LLC